Sarissa Capital Management LP

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001577524
Type: FundHoldings: 7Value: $154.7MLatest: 2025Q1

Sarissa Capital Management LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 7 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
7
Total Value
154710074
Accession Number
0000899140-25-000705
Form Type
13F-HR
Manager Name
Sarissa-Capital-Management-Lp
Data Enrichment
100% identified
7 identified0 unidentified

Holdings

7 positions • $154.7M total value
Manager:
Search and click to pin securities to the top
Innoviva, Inc.
Shares:2.8M
Value:$51.1M
% of Portfolio:33.0% ($51.1M/$154.7M)
NEUROCRINE BIOSCIENCES INC
Shares:309.1K
Value:$34.2M
% of Portfolio:22.1% ($34.2M/$154.7M)
CYTOKINETICS INC
Shares:600.0K
Value:$24.1M
% of Portfolio:15.6% ($24.1M/$154.7M)
IRONWOOD PHARMACEUTICALS INC
Shares:16.4M
Value:$24.1M
% of Portfolio:15.6% ($24.1M/$154.7M)
AMARIN CORP PLC\UK
Shares:24.9M
Value:$11.1M
% of Portfolio:7.2% ($11.1M/$154.7M)
Lantheus Holdings, Inc.
Shares:100.0K
Value:$9.8M
% of Portfolio:6.3% ($9.8M/$154.7M)
Vor Biopharma Inc.
Shares:508.0K
Value:$364.5K
% of Portfolio:0.2% ($364.5K/$154.7M)